Dr. Jason Marc Haffizulla, MD

Dr. Haffizulla practices at Medical Associates of Tamarac PA in Tamarac, Florida.

Dr. Haffizulla's NPI, 1033281191, was assigned on November 14, 2006. Dr. Haffizulla graduated from University of Miami, Miller School of Medicine in 2000. Dr. Haffizulla holds Florida license 0086704.

Dr. Haffizulla's primary practice is Medical Associates of Tamarac PA, at 7875 W Commercial Blvd, Tamarac, FL 33351 in Broward County. The practice phone is (954) 726-0099.

Dr. Haffizulla's primary practice is Medical Associates of Tamarac PA in Tamarac, Florida. Dr. Haffizulla is also affiliated with HCA Florida Woodmont Hospital. The medical group on file is Medical Associates of Tamarac. Dmand AI also links Dr. Haffizulla to 1 more group practice or clinic, 1 home health agency and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Haffizulla practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Haffizulla's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Haffizulla is board certified in internal medicine by the American Board of Internal Medicine. Dr. Haffizulla is licensed in Florida.

Dmand AI lists acid reflux, acute diabetes, acute skin infection, alzheimer's disease, aneurysm, anxiety, arteritis and arthritis among the conditions Dr. Haffizulla treats.

CMS data shows 1,421 Medicare services from Dr. Haffizulla across 23 procedure codes in 2024, for 241 Medicare patients. Medicare paid $58,562 for them. Every service was in an office.

CMS counts 241 Medicare patients who saw Dr. Haffizulla in 2024. The largest group is 65 to 74, with 105 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Haffizulla's median patient age at 58, with 61% women.

In 2024, Dr. Haffizulla wrote 14,748 Medicare Part D claims for 1,357 patients. 89% of them were for generic drugs. CMS names the drug for 13,800 of them, across 174 drugs with 11 or more claims each, at $862,062 in total drug cost. In 2023, CMS named 12,411 claims across 170 drugs.

Dr. Haffizulla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Haffizulla as offering telehealth.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Haffizulla, published from 2014 to 2022. Dr. Haffizulla's most frequent co-authors are Matthew P. Cheng, MD and Melanie Hoppers, MD.

Dmand AI links Dr. Haffizulla to 2 clinical trials. Conditions studied include Hypertriglyceridemia, Motor Activity and Hyperlipidemias. Open Payments lists research payments to Dr. Haffizulla that name 1 trial.

CMS Open Payments shows 1,568 general payments to Dr. Haffizulla from 93 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Novo Nordisk Inc paid the most, $3,002. It also lists 14 research payments totaling $103,860 from 2017 to 2024, naming 1 clinical trial.

Dr. Haffizulla graduated from University of Miami, Miller School of Medicine in 2000.

Dr. Haffizulla is in network with 7 carriers, including Aetna, United Healthcare and Aspirus Health Plan. PPO plans come from the most carriers, 4. Check the plan with the practice before a visit.